Dr. Paul Sieber and co-host Ashleigh Renitsky, Oncology PA, are joined by Dr. Morris from Urology Associates of Nashville to discuss how clinical guidelines have driven increased awareness of germline and somatic mutations in prostate cancer. They discuss how germline and somatic testing can help personalize treatment strategies and share real world case studies. The conversation also encourages the need for continued education in this rapidly advancing field and adoption of genetic testing in urology.
Podden och tillhörande omslagsbild på den här sidan tillhör
Myriad Genetics. Innehållet i podden är skapat av Myriad Genetics och inte av,
eller tillsammans med, Poddtoppen.
